Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS

CONTEXT: Women with polycystic ovary syndrome (PCOS) have an increased risk of cardiovascular disease (CVD), and biomarkers can be used to detect early subclinical CVD. Midregional-pro-adrenomedullin (MR-proADM), midregional-pro-atrial natriuretic peptide (MR-proANP) and copeptin are all associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Frøssing, Signe, Nylander, Malin, Kistorp, Caroline, Skouby, Sven O, Faber, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754509/
https://www.ncbi.nlm.nih.gov/pubmed/29295870
http://dx.doi.org/10.1530/EC-17-0327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754509/
https://www.ncbi.nlm.nih.gov/pubmed/29295870
http://dx.doi.org/10.1530/EC-17-0327

Ejemplares similares